Peripheral mechanisms of pain and analgesia
暂无分享,去创建一个
George L. Wilcox | Christoph Stein | Uhtaek Oh | R. Spencer | T. Vanderah | G. Wilcox | M. Vasko | J. Clark | J. David Clark | C. Stein | Michael R. Vasko | Aaron C. Overland | Todd W. Vanderah | Robert H. Spencer | U. Oh | J. Clark
[1] S. Snyder,et al. Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section , 1976, Brain Research.
[2] S. Ferreira,et al. I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. , 1979, Prostaglandins.
[3] A. Takemori,et al. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. , 1979, The Journal of pharmacology and experimental therapeutics.
[4] L. Iversen,et al. Multiple opiate receptor sites on primary afferent fibres , 1980, Nature.
[5] A. Takemori,et al. Interactions of leucine enkephalin and narcotics with opioid receptors. , 1981, Molecular pharmacology.
[6] J. Willer,et al. Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. , 1981, Science.
[7] G. Wilcox,et al. Intrathecal opioids block a spinal action of substance P in mice: Functional importance of both μ- and δ-receptors , 1982 .
[8] A. Takemori,et al. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. , 1983, The Journal of pharmacology and experimental therapeutics.
[9] R. Przewłocki,et al. Characterization and localization of immunoreactive dynorphin, α-neo-endorphin, met-enkephalin and substance P in human spinal cord , 1983, Brain Research.
[10] Y. Shavit,et al. Intrinsic mechanisms of pain inhibition: activation by stress. , 1984, Science.
[11] R. Saunders,et al. Outcomes and complications of continuous intraspinal narcotic analgesia for cancer pain control. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] E. Weihe,et al. Prodynorphin opioid peptides in small somatosensory primary afferents of guinea pig , 1985, Neuroscience Letters.
[13] B. Roth,et al. Differential ontogeny of multiple opioid receptors (mu, delta, and kappa) , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[14] J. Neale,et al. Localization of dynorphin gene product-immunoreactivity in neurons from spinal cord and dorsal root ganglia , 1986, Neuroscience.
[15] A. Dickenson,et al. Alpha 2-adrenoceptor modulation of nociception in rat spinal cord: location, effects and interactions with morphine. , 1987, European journal of pharmacology.
[16] G. Aghajanian,et al. Common α2- and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices , 1987, Neuropharmacology.
[17] D. L. Larson,et al. Hybrid bivalent ligands with opiate and enkephalin pharmacophores. , 1987, Journal of medicinal chemistry.
[18] G. Wilcox,et al. Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord , 1987, Brain Research.
[19] B. Dvorkin,et al. Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin , 1988, Brain Research.
[20] B. Meyerson,et al. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain , 1988, Pain.
[21] T. Yaksh,et al. Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies. , 1988, The Journal of pharmacology and experimental therapeutics.
[22] T. Yaksh. Substance P release from knee joint afferent terminals: modulation by opioids , 1988, Brain Research.
[23] A. Spiegel,et al. G proteins couple alpha-adrenergic and GABAb receptors to inhibition of peptide secretion from peripheral sensory neurons , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[24] J. Eisenach,et al. Epidural clonidine analgesia for intractable cancer pain: phase I. , 1989, Anesthesiology.
[25] S. Childers,et al. Modification of Gs‐Stimulated Adenylate Cyclase in Brain Membranes by Low pH Pretreatment: Correlation with Altered Guanine Nucleotide Exchange , 1988, Journal of neurochemistry.
[26] R. Dubner,et al. Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. , 1989, European journal of pharmacology.
[27] T. Shippenberg,et al. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. , 1989, The Journal of pharmacology and experimental therapeutics.
[28] A. Harmar,et al. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons , 1989, Nature.
[29] A. Kavelaars,et al. In Vitro β-Adrenergic Stimulation of Lymphocytes Induces the Release of Immunoreactive β-Endorphin , 1990 .
[30] A. Zinsmeister,et al. Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance. , 1990, The Journal of pharmacology and experimental therapeutics.
[31] H O Handwerker,et al. Properties of transdermal histamine iontophoresis: differential effects of season, gender, and body region. , 1990, The Journal of investigative dermatology.
[32] M. Ossipov,et al. Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. , 1990, Anesthesiology.
[33] R.A. LSHEEHAN‐DARE,et al. Anxiety and depression in patients with chronic urticaria and generalized pruritus , 1990, The British journal of dermatology.
[34] A. Herz,et al. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] K. Omote,et al. The antinociceptive role of mu- and delta-opiate receptors and their interactions in the spinal dorsal horn of cats. , 1990, Anesthesia and analgesia.
[36] M. Ossipov,et al. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates. , 1990, The Journal of pharmacology and experimental therapeutics.
[37] M. Ossipov,et al. Spinal antinociceptive synergy between clonidine and morphine, U69593, and DPDPE: isobolographic analysis. , 1990, Life sciences.
[38] R. Przewłocki,et al. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[39] H. Handwerker,et al. Discharge patterns of human C-fibers induced by itching and burning stimuli. , 1991, Journal of neurophysiology.
[40] A. Herz,et al. Analgesic effect of intraarticular morphine after arthroscopic knee surgery. , 1991, The New England journal of medicine.
[41] W. Mobley,et al. Hyperalgesia induced in the rat by the amino-terminal octapeptide of nerve growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[42] G. Wilcox,et al. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors. , 1992, The Journal of pharmacology and experimental therapeutics.
[43] W. Bowen,et al. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. , 1992, The Journal of pharmacology and experimental therapeutics.
[44] A. Malmberg,et al. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. , 1992, Science.
[45] P. Ernfors,et al. Colocalization of NGF binding sites, trk mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[46] R. Edwards,et al. Cloning of a delta opioid receptor by functional expression. , 1992, Science.
[47] R. Przewłocki,et al. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception , 1992, Neuroscience.
[48] P. Akins,et al. Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP , 1993, Neuroscience.
[49] H. Loh,et al. Immunofluorescent identification of a delta (delta)-opioid receptor on primary afferent nerve terminals. , 1993, Neuroreport.
[50] G. Uhl,et al. mu opiate receptor: cDNA cloning and expression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[51] A Goldstein,et al. Cloning and pharmacological characterization of a rat kappa opioid receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[52] Local analgesic effect of endogenous opioid peptides , 1993, The Lancet.
[53] D. Selley,et al. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. , 1993, Molecular pharmacology.
[54] A. Herz,et al. Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. , 1993, European journal of pharmacology.
[55] A. Herz,et al. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue , 1993, Neuroscience.
[56] M. Hamon,et al. Expression of Preproenkephalin A Gene and Presence of Met‐Enkephalin in Dorsal Root Ganglia of the Adult Rat , 1994, Journal of neurochemistry.
[57] M. Quartu,et al. Enkephalins occur and colocalize with substance P in human trigeminal ganglion neurones. , 1994, Neuroreport.
[58] C. Stein,et al. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[59] G. Burnstock,et al. Neuropeptide‐containing nerves in painful hypertrophic human scar tissue , 1994, The British journal of dermatology.
[60] J. A. Spitzer,et al. Prohormone convertases PC2 and PC3 in rat neutrophils and macrophages Parallel changes with proenkephalin-derived peptides induced by LPS in vivo , 1994, Neuropeptides.
[61] C. Woolf,et al. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity , 1994, Neuroscience.
[62] J. Eisenach,et al. An isobolographic study of epidural clonidine and fentanyl after cesarean section. , 1994, Anesthesia and analgesia.
[63] S. Rutkowski,et al. Intrathecal morphine and clonidine in the management of spinal cord injury pain: a case report , 1994, Pain.
[64] H. Akil,et al. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study , 1994, The Journal of comparative neurology.
[65] L. Mendell,et al. Peripheral and Central Mechanisms of NGF‐induced Hyperalgesia , 1994, The European journal of neuroscience.
[66] K. Befort,et al. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[67] R. Dobrowsky,et al. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. , 1994, Science.
[68] John T. Williams,et al. Opioid inhibition of Ih via adenylyl cyclase , 1994, Neuron.
[69] S. McMahon,et al. Immunocytochemical Localization of trkA Receptors in Chemically Identified Subgroups of Adult Rat Sensory Neurons , 1995, The European journal of neuroscience.
[70] F. Porreca,et al. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. , 1995, The Journal of pharmacology and experimental therapeutics.
[71] J. Maloteaux,et al. Interleukin-1β induces long-term increase of axonally transported opiate receptors and substance P , 1995, Neuroscience.
[72] M. Minami,et al. Double in situ hybridization study on coexistence of μ-, δ- and κ-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia , 1995 .
[73] S. McMahon,et al. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule , 1995, Nature Medicine.
[74] M. Vasko,et al. Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascade , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[75] J. Levine,et al. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[76] C. Stein,et al. Perineurial defect and peripheral opioid analgesia in inflammation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[77] J. Eisenach,et al. Epidural clonidine analgesia for intractable cancer pain , 1995, Pain.
[78] P. Law,et al. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[79] H. Loh,et al. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[80] C. Stein. The control of pain in peripheral tissue by opioids. , 1995, The New England journal of medicine.
[81] M. Scheinin,et al. Molecular pharmacology of α2-adrenoceptor subtypes , 1995 .
[82] Timothy J. Brennan,et al. Characterization of a rat model of incisional pain , 1996, Pain.
[83] C. Stein,et al. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[84] J. Besson,et al. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study. , 1996, The Journal of pharmacology and experimental therapeutics.
[85] T. Kaneko,et al. Effects of peripheral nerve ligation on expression of μ-opioid receptor in sensory ganglion neurons: an immunohistochemical study in dorsal root and nodose ganglion neurons of the rat , 1996, Neuroscience Letters.
[86] S. McMahon. NGF as a mediator of inflammatory pain. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[87] A. Hassan,et al. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. , 1996, European journal of pharmacology.
[88] L. Mendell,et al. Nerve growth factor NT-5 induce increased thermal sensitivity of cutaneous nociceptors in vitro. , 1996, Journal of neurophysiology.
[89] M. von Zastrow,et al. Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[90] M. Vasko,et al. Activation of Protein Kinase C Augments Peptide Release from Rat Sensory Neurons , 1996, Journal of neurochemistry.
[91] A. Hassan,et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. , 1996, The Journal of clinical investigation.
[92] J. Levine,et al. DAMGO inhibits prostaglandin E2-induced potentiation of a TTX-resistant Na+ current in rat sensory neurons in vitro , 1996, Neuroscience Letters.
[93] S. Skaper,et al. Nerve growth factor: from neurotrophin to neurokine , 1996, Trends in Neurosciences.
[94] K. Mackie,et al. Modulation of Ca2+ channels βγ G-protein py subunits , 1996, Nature.
[95] R. Amann,et al. Intraplantar injection of nerve growth factor into the rat hind paw: local edema and effects on thermal nociceptive threshold , 1996, Pain.
[96] D. Kim,et al. Capsaicin activates a nonselective cation channel in cultured neonatal rat dorsal root ganglion neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[97] C. Woolf,et al. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[98] O. Simell,et al. Recirculation and homing of lymphocyte subsets: dual homing specificity of beta 7-integrin(high)-lymphocytes in nonobese diabetic mice. , 1996, Blood.
[99] K. J. Oswald,et al. Alpha 2A-adrenergic receptor stimulated calcium release is transduced by Gi-associated G(beta gamma)-mediated activation of phospholipase C. , 1997, Biochemistry.
[100] Hermann O. Handwerker,et al. Specific C-Receptors for Itch in Human Skin , 1997, The Journal of Neuroscience.
[101] R. Coggeshall,et al. Immunohistochemical localization of enkephalin in peripheral sensory axons in the rat , 1997, Neuroscience Letters.
[102] V. Pickel,et al. Dual ultrastructural immunocytochemical labeling of μ and δ opioid receptors in the superficial layers of the rat cervical spinal cord , 1997, Brain Research.
[103] H. Handwerker,et al. Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis , 1997, Pain.
[104] C. Woolf,et al. The progressive tactile hyperalgesia induced by peripheral inflammation is nerve growth factor dependent , 1997, Neuroreport.
[105] J. Wood,et al. Chemical activators of sensory neurons. , 1997, Annual review of physiology.
[106] D. Steiner,et al. Expression of PC3, carboxypeptidase E and enkephalin in human monocyte‐derived macrophages as a tool for genetic studies , 1997, FEBS letters.
[107] T. Hökfelt,et al. Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study , 1997, Neuroscience.
[108] B. Cox,et al. Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction , 1997, Neuroscience.
[109] T. Brennan,et al. Effect of Systemic and Intrathecal Morphine in a Rat Model of Postoperative Pain , 1997, Anesthesiology.
[110] J. Levine,et al. Different Mechanisms Mediate Development and Expression of Tolerance and Dependence for Peripheral μ-Opioid Antinociception in Rat , 1997, The Journal of Neuroscience.
[111] D. Julius,et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.
[112] J. J. Chen,et al. Regulation of opioid receptors in rat sensory neurons in culture. , 1997, Molecular pharmacology.
[113] R. Coggeshall,et al. Opioid receptors on peripheral sensory axons , 1997, Brain Research.
[114] G. Bernatzky,et al. Intraarticular Morphine Analgesia in Chronic Pain Patients with Osteoarthritis , 1997, Anesthesia and analgesia.
[115] M. Scheinin,et al. Gene targeting — homing in on α2-adrenoceptor-subtype function , 1997 .
[116] T. Hökfelt,et al. Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles , 1997, Neuroscience.
[117] M. Hashiro,et al. Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity. , 1997, Journal of dermatological science.
[118] M. Tramèr,et al. Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials , 1997, Pain.
[119] J. Loeffler,et al. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. , 1997, The Journal of clinical investigation.
[120] T. Hökfelt,et al. Down-regulation of μ-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy , 1997, Neuroscience.
[121] M. Murakami,et al. Cyclooxygenase-2-dependent delayed prostaglandin D2 generation is initiated by nerve growth factor in rat peritoneal mast cells: its augmentation by extracellular type II secretory phospholipase A2. , 1997, Journal of immunology.
[122] J. Blalock,et al. Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes , 1997, Journal of Neuroimmunology.
[123] L. Stone,et al. The α2a Adrenergic Receptor Subtype Mediates Spinal Analgesia Evoked by α2 Agonists and Is Necessary for Spinal Adrenergic–Opioid Synergy , 1997, The Journal of Neuroscience.
[124] E. Bröcker,et al. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. , 1998, The American journal of pathology.
[125] J. Pintar,et al. Developmental Expression of the μ, κ, and δ Opioid Receptor mRNAs in Mouse , 1998, The Journal of Neuroscience.
[126] M. Wessendorf,et al. Immunoreactivity for endomorphin‐2 occurs in primary afferents in rats and monkey , 1998, Neuroreport.
[127] J. Lopshire,et al. The cAMP Transduction Cascade Mediates the Prostaglandin E2 Enhancement of the Capsaicin-Elicited Current in Rat Sensory Neurons: Whole-Cell and Single-Channel Studies , 1998, The Journal of Neuroscience.
[128] R. Elde,et al. Effects of neurotoxins and hindpaw inflammation on opioid receptor immunoreactivities in dorsal root ganglia , 1998, Neuroscience.
[129] A. Wittinghofer,et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP , 1998, Nature.
[130] P. Cabot,et al. Pain control in inflammation governed by selectins , 1998, Nature Medicine.
[131] T. Kaneko,et al. Immunocytochemical localization of μ-opioid receptor in primary afferent neurons containing substance P or calcitonin gene-related peptide. A light and electron microscope study in the rat , 1998, Brain Research.
[132] T. Hökfelt,et al. Differential Distribution of a 2 A and a 2 C Adrenergic Receptor Immunoreactivity in the Rat Spinal Cord , 1998 .
[133] R. Shigemoto,et al. GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.
[134] Q. Zhang,et al. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. , 1998, The Journal of pharmacology and experimental therapeutics.
[135] A. Kastin,et al. Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers , 1998, Peptides.
[136] M. Koltzenburg,et al. Nerve growth factor regulates the expression of bradykinin binding sites on adult sensory neurons via the neurotrophin receptor p75 , 1998, Neuroscience.
[137] T. Hökfelt,et al. Differential Distribution of α2A and α2C Adrenergic Receptor Immunoreactivity in the Rat Spinal Cord , 1998, The Journal of Neuroscience.
[138] S. Waxman,et al. Sodium channel expression in NGF‐overexpressing transgenic mice , 1999, Journal of neuroscience research.
[139] L. Mendell,et al. Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin , 1999, Neuroscience Letters.
[140] C. Stein,et al. Intraarticular morphine versus dexamethasone in chronic arthritis , 1999, PAIN®.
[141] C. Stein,et al. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans. , 1999, The Journal of pharmacology and experimental therapeutics.
[142] C. N. Honda,et al. Immunohistochemical localization of delta opioid receptors in peripheral tissues , 1999, The Journal of comparative neurology.
[143] H. Loh,et al. δ-opioid-induced liberation of Gβγ mobilizes Ca2+ stores in NG108- 15 cells , 1999 .
[144] M. Millan,et al. The induction of pain: an integrative review , 1999, Progress in Neurobiology.
[145] D. Julius,et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide , 1999, Nature.
[146] A. Zimmer,et al. Preproenkephalin is a Th2 cytokine but is not required for Th2 differentiation in vitro , 1999, Immunology and cell biology.
[147] J. Bienenstock,et al. Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. , 1999, Journal of immunology.
[148] Ji Ming Wang,et al. Inhibition of chemokine-induced chemotaxis of monkey leukocytes by mu-opioid receptor agonists. , 1999, In vivo.
[149] M. Connor,et al. OPIOID RECEPTOR SIGNALLING MECHANISMS , 1999, Clinical and experimental pharmacology & physiology.
[150] Vicki Brower,et al. New paths to pain relief , 2000, Nature Biotechnology.
[151] C. Mackay,et al. T-cell function and migration. Two sides of the same coin. , 2000, The New England journal of medicine.
[152] S. Bingham,et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia , 2000, Nature.
[153] J. Levine,et al. Chronic Hypersensitivity For Inflammatory Nociceptor Sensitization Mediated by the ε Isozyme of Protein Kinase C , 2000, The Journal of Neuroscience.
[154] F. Cunha,et al. Cytokine‐mediated inflammatory hyperalgesia limited by interleukin‐1 receptor antagonist , 2000, British journal of pharmacology.
[155] L. Stone,et al. Moxonidine, a selective imidazoline/α 2 adrenergic receptor agonist, synergizes with morphine and deltorphin II to inhibit substance P-induced behavior in mice , 2000, Pain.
[156] H. Loh,et al. Molecular mechanisms and regulation of opioid receptor signaling. , 2000, Annual review of pharmacology and toxicology.
[157] H. Loh,et al. Association of kappa opioid receptor mRNA upregulation in dorsal root ganglia with mechanical allodynia in mice following nerve injury , 2000, Neuroscience Letters.
[158] J. Wang,et al. Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response. , 2000, Immunopharmacology.
[159] C. Woolf,et al. Neuronal plasticity: increasing the gain in pain. , 2000, Science.
[160] C. Stein,et al. Co-expression of β-endorphin with adhesion molecules in a model of inflammatory pain , 2000, Journal of Neuroimmunology.
[161] K. Peter,et al. Continuous axillary brachial plexus analgesia with low dose morphine in patients with complex regional pain syndromes. , 2000, European journal of anaesthesiology.
[162] S. McMahon,et al. Intrathecally injected neurotrophins and the release of substance P from the rat isolated spinal cord , 2000, The European journal of neuroscience.
[163] S. Hwang,et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[164] A I Basbaum,et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. , 2000, Science.
[165] D. Hammond,et al. Synergistic interactions between two α 2-adrenoceptor agonists, dexmedetomidine and ST-91, in two substrains of Sprague–Dawley rats , 2000, Pain.
[166] A. Craig,et al. Spinothalamic lamina I neurones selectively responsive to cutaneous warming in cats , 2001, The Journal of physiology.
[167] C. Stein,et al. Peripheral analgesic and antiinflammatory effects of opioids , 2001, Zeitschrift für Rheumatologie.
[168] M. Angst,et al. Opioid-Induced Hyperalgesia and Incisional Pain , 2001, Anesthesia and analgesia.
[169] R. Ji,et al. β-Endorphin-containing memory-cells and μ-opioid receptors undergo transport to peripheral inflamed tissue , 2001, Journal of Neuroimmunology.
[170] D. Simone,et al. Peripheral and preemptive opioid antinociception in a mouse visceral pain model , 2001, Pain.
[171] R J Miller,et al. Chemokines and Glycoprotein120 Produce Pain Hypersensitivity by Directly Exciting Primary Nociceptive Neurons , 2001, The Journal of Neuroscience.
[172] S. Gordon,et al. Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation , 2001, Clinical pharmacology and therapeutics.
[173] A. Beaudet,et al. Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: Evidence for somatodendritic labeling and antigen‐specific cellular compartmentalization , 2001, The Journal of comparative neurology.
[174] L. Mendell,et al. Acute sensitization by NGF of the response of small-diameter sensory neurons to capsaicin. , 2001, Journal of neurophysiology.
[175] J. Kraus,et al. Regulation of μ-Opioid Receptor Gene Transcription by Interleukin-4 and Influence of an Allelic Variation within a STAT6 Transcription Factor Binding Site* , 2001, The Journal of Biological Chemistry.
[176] M. Southall,et al. Prostaglandin Receptor Subtypes, EP3C and EP4, Mediate the Prostaglandin E2-induced cAMP Production and Sensitization of Sensory Neurons* , 2001, The Journal of Biological Chemistry.
[177] A. Moriondo,et al. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide , 2001, The Journal of physiology.
[178] Huan Wang,et al. Equal proportions of small and large DRG neurons express opioid receptor mRNAs , 2001, The Journal of comparative neurology.
[179] M. Fitzgerald,et al. Mu- and delta-opioid receptors are downregulated in the largest diameter primary sensory neurons during postnatal development in rats , 2001, Pain.
[180] S. McMahon,et al. Nerve growth factor induces P2X3 expression in sensory neurons , 2001, Journal of neurochemistry.
[181] D. Lysle,et al. Morphine modulation of the contact hypersensitivity response: characterization of immunological changes. , 2001, Clinical immunology.
[182] P. Cabot,et al. Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain , 2001, Pain.
[183] H. Rittner,et al. Opioid Peptide–expressing Leukocytes: Identification, Recruitment, and Simultaneously Increasing Inhibition of Inflammatory Pain , 2001, Anesthesiology.
[184] H. Junger,et al. Effects of full-thickness burns on nociceptor sensitization in anesthetized rats. , 2002, Burns : journal of the International Society for Burn Injuries.
[185] M. von Zastrow,et al. Modulation of Postendocytic Sorting of G Protein-Coupled Receptors , 2002, Science.
[186] M. Millan. Descending control of pain , 2002, Progress in Neurobiology.
[187] S. Hwang,et al. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[188] H. Shannon,et al. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats , 2002, Neuropharmacology.
[189] J. Deleo,et al. The Role of Spinal Neuroimmune Activation in Morphine Tolerance/Hyperalgesia in Neuropathic and Sham-Operated Rats , 2002, The Journal of Neuroscience.
[190] C. Stein,et al. Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain , 2002, Journal of Neuroimmunology.
[191] T. Vanderah,et al. Sustained Morphine Exposure Induces a Spinal Dynorphin-Dependent Enhancement of Excitatory Transmitter Release from Primary Afferent Fibers , 2002, The Journal of Neuroscience.
[192] J. Glorioso,et al. Targeted gene delivery to the nervous system using herpes simplex virus vectors , 2002, Physiology & Behavior.
[193] E. Kalso,et al. No pain, no gain: clinical excellence and scientific rigour – lessons learned from IA morphine , 2002, Pain.
[194] H. Rittner,et al. Opioid Control of Inflammatory Pain Regulated by Intercellular Adhesion Molecule-1 , 2002, The Journal of Neuroscience.
[195] C. Woolf,et al. p38 MAPK Activation by NGF in Primary Sensory Neurons after Inflammation Increases TRPV1 Levels and Maintains Heat Hyperalgesia , 2002, Neuron.
[196] M. Southall,et al. Twenty-four hour exposure to prostaglandin downregulates prostanoid receptor binding but does not alter PGE2-mediated sensitization of rat sensory neurons , 2002, Pain.
[197] C. Gaveriaux-Ruff,et al. Exploring the opioid system by gene knockout , 2002, Progress in Neurobiology.
[198] M. Brede,et al. Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[199] M. Adler,et al. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[200] C. Svensson,et al. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. , 2002, Annual review of pharmacology and toxicology.
[201] R. Schulz,et al. Chronic Morphine Treatment Inhibits Opioid Receptor Desensitization and Internalization , 2002, The Journal of Neuroscience.
[202] M. Gunzer,et al. Localization of μ-opioid receptor 1A on sensory nerve fibers in human skin , 2002, Regulatory Peptides.
[203] L. Stone,et al. alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. , 2002, The Journal of pharmacology and experimental therapeutics.
[204] John E. Murphy,et al. Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury , 2003, Nature Medicine.
[205] L. Klesse,et al. Activation of Ras is necessary and sufficient for upregulation of vanilloid receptor type 1 in sensory neurons by neurotrophic factors , 2003, Molecular and Cellular Neuroscience.
[206] M. Welte,et al. Modulation of Peripheral Endogenous Opioid Analgesia by Central Afferent Blockade , 2003, Anesthesiology.
[207] Eric M. Smith,et al. Opioid peptides in immune cells. , 2003, Advances in experimental medicine and biology.
[208] Jörn Lötsch,et al. Peripheral opioid analgesia in experimental human pain models. , 2003, Brain : a journal of neurology.
[209] M. Hamon,et al. Gene therapy of chronic pain. , 2003, Current gene therapy.
[210] M. Chao,et al. Neurotrophins and their receptors: A convergence point for many signalling pathways , 2003, Nature Reviews Neuroscience.
[211] D. Zochodne,et al. μ Opioid receptors and analgesia at the site of a peripheral nerve injury , 2003 .
[212] E. Huang,et al. Trk receptors: roles in neuronal signal transduction. , 2003, Annual review of biochemistry.
[213] C. Stein,et al. Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. , 2003, Molecular pharmacology.
[214] W. Swaim,et al. Immunohistochemical localization of mu-opioid receptors in human dental pulp. , 2003, Journal of endodontics.
[215] S. Raja,et al. A Mouse Model of Incisional Pain , 2003, Anesthesiology.
[216] T. Hökfelt,et al. Activation of Delta Opioid Receptors Induces Receptor Insertion and Neuropeptide Secretion , 2003, Neuron.
[217] J. Eisenach,et al. Analgesia from a peripherally active κ-opioid receptor agonist in patients with chronic pancreatitis , 2003, Pain.
[218] L. Devi,et al. Functional interactions between mu opioid and alpha 2A-adrenergic receptors. , 2003, Molecular pharmacology.
[219] L. Mendell,et al. Mechanisms of sensitization of the response of single dorsal root ganglion cells from adult rat to noxious heat , 2003, The European journal of neuroscience.
[220] F. Cunha,et al. Peripheral hyperalgesic cytokines. , 2003, Advances in experimental medicine and biology.
[221] J. Sawynok. Topical and Peripherally Acting Analgesics , 2003, Pharmacological Reviews.
[222] C. Stein,et al. Different mechanisms of intrinsic pain inhibition in early and late inflammation , 2003, Journal of Neuroimmunology.
[223] D. Zochodne,et al. Mu opioid receptors and analgesia at the site of a peripheral nerve injury. , 2003, Annals of neurology.
[224] E. Mccleskey,et al. Quantitative Single-Cell Differences in μ-Opioid Receptor mRNA Distinguish Myelinated and Unmyelinated Nociceptors , 2003, The Journal of Neuroscience.
[225] C. Stein,et al. Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain , 2003, Pain.
[226] J. McArthur,et al. New insights into diabetic polyneuropathy. , 2003, JAMA.
[227] C. Gaveriaux-Ruff,et al. Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. , 2003, The Journal of clinical investigation.
[228] C. Stein,et al. Attacking pain at its source: new perspectives on opioids , 2003, Nature Medicine.
[229] P. McNaughton,et al. Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor , 2003, The Journal of physiology.
[230] A. Beaudet,et al. Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia , 2003, The Journal of comparative neurology.
[231] T. Kaneko,et al. Expression and G-protein coupling of μ-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats , 2003, Neuropeptides.
[232] H O Handwerker,et al. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. , 2003, Journal of neurophysiology.
[233] P. Rivière. Peripheral kappa‐opioid agonists for visceral pain , 2004, British journal of pharmacology.
[234] R. Reszka,et al. Tissue Monocytes/Macrophages in Inflammation: Hyperalgesia versus Opioid-mediated Peripheral Antinociception , 2004, Anesthesiology.
[235] M. Costa,et al. Pathway-specific patterns of the co-existence of substance P, calcitonin gene-related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea-pig , 1987, Cell and Tissue Research.
[236] M. Shakibaei,et al. Subcellular Pathways of β-Endorphin Synthesis, Processing, and Release from Immunocytes in Inflammatory Pain , 2004 .
[237] S. Maier,et al. A Role for Proinflammatory Cytokines and Fractalkine in Analgesia, Tolerance, and Subsequent Pain Facilitation Induced by Chronic Intrathecal Morphine , 2004, The Journal of Neuroscience.
[238] G. Geisslinger,et al. Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications , 2004, Pharmacological Reviews.
[239] P. Cabot,et al. Reduction of &bgr;-Endorphin-Containing Immune Cells in Inflamed Paw Tissue Corresponds with a Reduction in Immune-Derived Antinociception: Reversible by Donor Activated Lymphocytes , 2004, Anesthesia and analgesia.
[240] K. Valentino,et al. Ultrastructural studies on calcitonin gene-related peptide-, tachykinins- and somatostatin-immunoreactive neurones in rat dorsal root ganglia: Evidence for the colocalization of different peptides in single secretory granules , 1988, Cell and Tissue Research.
[241] H. Rittner,et al. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells , 2004, Pain.
[242] A. Ahmadiani,et al. Involvement of Interleukin‐1β in Systemic Morphine Effects on Paw Oedema in a Mouse Model of Acute Inflammation , 2004, Scandinavian journal of immunology.
[243] L. Stone,et al. Alpha-2-adrenergic and opioid receptor additivity in rat locuscoeruleus neurons , 2004, Neuroscience Letters.
[244] D. Clapham,et al. Phosphatidylinositol 3-Kinase Activates ERK in Primary Sensory Neurons and Mediates Inflammatory Heat Hyperalgesia through TRPV1 Sensitization , 2004, The Journal of Neuroscience.
[245] H. Ueda,et al. Loss of Peripheral Morphine Analgesia Contributes to the Reduced Effectiveness of Systemic Morphine in Neuropathic Pain , 2004, Journal of Pharmacology and Experimental Therapeutics.
[246] Y. H. Zhang,et al. NGF-mediated sensitization of the excitability of rat sensory neurons is prevented by a blocking antibody to the p75 neurotrophin receptor , 2004, Neuroscience Letters.
[247] L. Stone,et al. Alpha-2-adrenergic and opioid receptor additivity in rat locus coeruleus neurons. , 2004, Neuroscience letters.
[248] R. Rush,et al. Elevated Nerve Growth Factor Levels in the Synovial Fluid of Patients with Inflammatory Joint Disease , 1998, Neurochemical Research.
[249] C. Stein,et al. Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue , 2004, The European journal of neuroscience.
[250] V. Di Marzo,et al. Actions of two naturally occurring saturated N‐acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels , 2004, British journal of pharmacology.
[251] R. Likar,et al. Increased numbers of opioid expressing inflammatory cells do not affect intra-articular morphine analgesia. , 2004, British journal of anaesthesia.
[252] A. Herz,et al. Involvement of capsaicin-sensitive neurones in hyperalgesia and enhanced opioid antinociception in inflammation , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.
[253] P. Rivière,et al. FE200041 (d-Phe-d-Phe-d-Nle-d-Arg-NH2): A Peripheral Efficacious κ Opioid Agonist with Unprecedented Selectivity , 2004, Journal of Pharmacology and Experimental Therapeutics.
[254] D. Weinreich,et al. Bradykinin decreases K+ and increases Cl− conductances in vagal afferent neurones of the guinea pig , 2004, The Journal of physiology.
[255] C. Stein,et al. Characterization of μ Opioid Receptor Binding and G Protein Coupling in Rat Hypothalamus, Spinal Cord, and Primary Afferent Neurons during Inflammatory Pain , 2004, Journal of Pharmacology and Experimental Therapeutics.
[256] A. Brack,et al. Rapid upregulation of μ opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction , 2004, Neuroscience.
[257] H. Rittner,et al. Selectins and integrins but not platelet–endothelial cell adhesion molecule‐1 regulate opioid inhibition of inflammatory pain , 2004, British journal of pharmacology.
[258] R. Dolle,et al. Peripherally restricted opioid agonists as novel analgesic agents. , 2004, Current pharmaceutical design.
[259] H. Rittner,et al. Mobilization of Opioid-containing Polymorphonuclear Cells by Hematopoietic Growth Factors and Influence on Inflammatory Pain , 2004, Anesthesiology.
[260] R. Przewłocki,et al. Peripheral versus Central Antinociceptive Actions of 6-Amino Acid-Substituted Derivatives of 14-O-Methyloxymorphone in Acute and Inflammatory Pain in the Rat , 2005, Journal of Pharmacology and Experimental Therapeutics.
[261] David J. Daniels,et al. Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[262] F. Cunha,et al. Nociceptive Effect of Subcutaneously Injected Interleukin-12 Is Mediated by Endothelin (ET) Acting on ETB Receptors in Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.
[263] Y. Hannun,et al. The Coordination of Prostaglandin E2 Production by Sphingosine-1-phosphate and Ceramide-1-phosphate , 2005, Molecular Pharmacology.
[264] F. Leblond,et al. Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: A new model of neuropathic pain , 2005, Neuroscience.
[265] M. Banck,et al. Intrathecal gene transfer by adeno-associated virus for pain. , 2005, Current opinion in molecular therapeutics.
[266] B. Plytycz,et al. Morphine-induced changes in the activity of proopiomelanocortin and prodynorphin systems in zymosan-induced peritonitis in mice. , 2005, Immunology letters.
[267] M. Fung,et al. Randomized, Double-blind Study of the Analgesic Efficacy of Morphine-6-Glucuronide versus Morphine Sulfate for Postoperative Pain in Major Surgery , 2005, Anesthesiology.
[268] F. Cunha,et al. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[269] K. K. Rau,et al. Diverse immunocytochemical expression of opioid receptors in electrophysiologically defined cells of rat dorsal root ganglia , 2005, Journal of Chemical Neuroanatomy.
[270] P. McNaughton,et al. NGF rapidly increases membrane expression of TRPV1 heat‐gated ion channels , 2005, The EMBO journal.
[271] F. Rice,et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[272] S. Schulz,et al. Receptor Endocytosis Counteracts the Development of Opioid Tolerance , 2005, Molecular Pharmacology.
[273] J. Levine,et al. Epac Mediates a cAMP-to-PKC Signaling in Inflammatory Pain: An Isolectin B4(+) Neuron-Specific Mechanism , 2005, The Journal of Neuroscience.
[274] B. Song,et al. Inhibition by Spinal μ- and δ-Opioid Agonists of Afferent-Evoked Substance P Release , 2005, The Journal of Neuroscience.
[275] T. Brennan,et al. Increased nerve growth factor after rat plantar incision contributes to guarding behavior and heat hyperalgesia , 2005, Pain.
[276] O. Krishtal,et al. Opioids inhibit purinergic nociceptors in the sensory neurons and fibres of rat via a G protein-dependent mechanism , 2005, Neuropharmacology.
[277] Sabita Roy,et al. Morphine Impairs Host Innate Immune Response and Increases Susceptibility to Streptococcus pneumoniae Lung Infection1 , 2005, The Journal of Immunology.
[278] K. Hargreaves,et al. Bradykinin-Induced Functional Competence and Trafficking of the δ-Opioid Receptor in Trigeminal Nociceptors , 2005, The Journal of Neuroscience.
[279] A. Lastra,et al. Effects of the local administration of selective μ-, δ-and κ-opioid receptor agonists on osteosarcoma-induced hyperalgesia , 2005, Naunyn-Schmiedeberg's Archives of Pharmacology.
[280] U. Oh. Chapter 5 Nociceptive Signals to TRPV1 and its Clinical Potential , 2006 .
[281] Martin S. Angst,et al. Opioid-induced Hyperalgesia: A Qualitative Systematic Review , 2006, Anesthesiology.
[282] I. Bileviciute-Ljungar,et al. Peripherally Mediated Antinociception of the μ-Opioid Receptor Agonist 2-[(4,5α-Epoxy-3-hydroxy-14β-methoxy-17-methylmorphinan-6β-yl)amino]acetic Acid (HS-731) after Subcutaneous and Oral Administration in Rats with Carrageenan-Induced Hindpaw Inflammation , 2006, Journal of Pharmacology and Experimental Therapeutics.
[283] M. Angst,et al. Blockade of the Complement C5a Receptor Reduces Incisional Allodynia, Edema, and Cytokine Expression , 2006, Anesthesiology.
[284] F. Liew,et al. IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[285] T. Jessell,et al. Runx1 Determines Nociceptive Sensory Neuron Phenotype and Is Required for Thermal and Neuropathic Pain , 2006, Neuron.
[286] A. Kreicbergs,et al. Opioid peptides and receptors in joint tissues: Study in the rat , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[287] W. Bowles,et al. Chronic nerve growth factor administration increases the peripheral exocytotic activity of capsaicin-sensitive cutaneous neurons , 2006, Neuroscience Letters.
[288] O. Valverde,et al. Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain , 2006, Neuropharmacology.
[289] I. Vetter,et al. The effects of pH on beta-endorphin and morphine inhibition of calcium transients in dorsal root ganglion neurons. , 2006, The journal of pain : official journal of the American Pain Society.
[290] S. Hua,et al. The Neural Cell Adhesion Molecule Antibody Blocks Cold Water Swim Stress-Induced Analgesia and Cell Adhesion Between Lymphocytes and Cultured Dorsal Root Ganglion Neurons , 2006, Anesthesia and analgesia.
[291] H. Rittner,et al. Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain , 2006, Journal of leukocyte biology.
[292] A. Beaudet,et al. Morphine and Pain-Related Stimuli Enhance Cell Surface Availability of Somatic δ-Opioid Receptors in Rat Dorsal Root Ganglia , 2006, The Journal of Neuroscience.
[293] S. Schulz,et al. Pain control by CXCR2 ligands through Ca2+ ‐regulated release of opioid peptides from polymorphonuclear cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[294] H. Rittner,et al. Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation , 2006, Neuroscience.
[295] P. Morley-Forster,et al. A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008--a long-acting, parenteral opioid analgesic--in the treatment of postherpetic neuralgia. , 2006, Journal of opioid management.
[296] W. Khan,et al. CD4+ T-cell modulation of visceral nociception in mice. , 2006, Gastroenterology.
[297] Á. Meana,et al. Endogenous β-endorphin induces thermal analgesia at the initial stages of a murine osteosarcoma , 2006, Peptides.
[298] H. Rittner,et al. Peripheral Antinociceptive Effects of Exogenous and Immune Cell-Derived Endomorphins in Prolonged Inflammatory Pain , 2006, The Journal of Neuroscience.
[299] J. Guan,et al. Role of delivery and trafficking of δ-opioid peptide receptors in opioid analgesia and tolerance , 2006 .
[300] J. Bos,et al. Epac proteins: multi-purpose cAMP targets. , 2006, Trends in biochemical sciences.
[301] A. Stein,et al. Phosphoinositide 3-Kinase Binds to TRPV1 and Mediates NGF-stimulated TRPV1 Trafficking to the Plasma Membrane , 2006, The Journal of general physiology.
[302] P. Dubus,et al. μ-Opioid receptor activation prevents acute hepatic inflammation and cell death , 2007, Gut.
[303] T. Brennan,et al. Nerve Growth Factor Expression after Plantar Incision in the Rat , 2007, Anesthesiology.
[304] S. Milam,et al. Integrins regulate opioid receptor signaling in trigeminal ganglion neurons , 2007, Neuroscience.
[305] C. Cahill,et al. Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain , 2007, Pain.
[306] R. Straub,et al. β-Endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis , 2007 .
[307] Weiguo Zhu,et al. Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1 , 2007, Molecular and Cellular Neuroscience.
[308] Misook Kim,et al. TRPV1 Mediates Histamine-Induced Itching via the Activation of Phospholipase A2 and 12-Lipoxygenase , 2007, The Journal of Neuroscience.
[309] R. Przewłocki,et al. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. , 2007, European journal of pharmacology.
[310] H. Machelska. Targeting of opioid-producing leukocytes for pain control , 2007, Neuropeptides.
[311] Yan-Gang Sun,et al. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord , 2007, Nature.
[312] Graeme Milligan,et al. G protein-coupled receptor dimerisation: molecular basis and relevance to function. , 2007, Biochimica et biophysica acta.
[313] R. Likar,et al. Involvement of Intra-articular Corticotropin-releasing Hormone in Postoperative Pain Modulation , 2007, The Clinical journal of pain.
[314] W. Maixner,et al. Effects of carrageenan and morphine on acute inflammation and pain in Lewis and Fischer rats , 2007, Brain, Behavior, and Immunity.
[315] J. Pin,et al. Activation of a Dimeric Metabotropic Glutamate Receptor by Intersubunit Rearrangement* , 2007, Journal of Biological Chemistry.
[316] H. Rittner,et al. Neurokinin-1 Receptor Antagonists Inhibit the Recruitment of Opioid-containing Leukocytes and Impair Peripheral Antinociception , 2007, Anesthesiology.
[317] C. Stein,et al. Relative contribution of peripheral versus central opioid receptors to antinociception , 2007, Brain Research.
[318] R. Hellweg,et al. Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. , 2007, Brain : a journal of neurology.
[319] K. Hargreaves,et al. Rapid Modulation of μ-Opioid Receptor Signaling in Primary Sensory Neurons , 2007, Journal of Pharmacology and Experimental Therapeutics.
[320] H. Rittner,et al. CXCR1/2 ligands induce p38 MAPK-dependent translocation and release of opioid peptides from primary granules in vitro and in vivo , 2007, Brain, Behavior, and Immunity.
[321] M. Welte,et al. Influence of pain treatment by epidural fentanyl and bupivacaine on homing of opioid-containing leukocytes to surgical wounds , 2007, Brain, Behavior, and Immunity.
[322] J. Puzas,et al. Amelioration of pain and histopathologic joint abnormalities in the Col1-IL-1beta(XAT) mouse model of arthritis by intraarticular induction of mu-opioid receptor into the temporomandibular joint. , 2007, Arthritis and rheumatism.
[323] Jakub Fichna,et al. The Endomorphin System and Its Evolving Neurophysiological Role , 2007, Pharmacological Reviews.
[324] P. Heppenstall,et al. μ-Opioid Receptor Activation Modulates Transient Receptor Potential Vanilloid 1 (TRPV1) Currents in Sensory Neurons in A Model of Inflammatory Pain , 2007, Molecular Pharmacology.
[325] M. Angst,et al. Morphine reduces local cytokine expression and neutrophil infiltration after incision , 2007, Molecular pain.
[326] L. Huang,et al. A critical role of the cAMP sensor Epac in switching protein kinase signalling in prostaglandin E2‐induced potentiation of P2X3 receptor currents in inflamed rats , 2007, The Journal of physiology.
[327] H. Rittner,et al. Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and beta-endorphin during painful inflammation in vivo , 2007, Journal of Neuroimmunology.
[328] L. Gibson,et al. Effect of Morphine Sulfate on Neonatal Neutrophil Chemotaxis , 2008, The Clinical journal of pain.
[329] R. Meyer,et al. Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury , 2008, PAIN.
[330] F. Liew,et al. Role of IL-18 in overt pain-like behaviour in mice. , 2008, European journal of pharmacology.
[331] Z. Sheng,et al. Coexistence and upregulation of three types of opioid receptors, mu, delta and kappa, in human hypertrophic scars , 2008, The British journal of dermatology.
[332] M. Shakibaei,et al. Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. , 2008, The Journal of clinical investigation.
[333] A. Mangel,et al. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome , 2008, Alimentary pharmacology & therapeutics.
[334] A. Basbaum,et al. The senses : a comprehensive reference , 2008 .
[335] J. Levine,et al. Proinflammatory cytokines mediating burn-injury pain , 2008, PAIN®.
[336] R. Straub,et al. Antiinflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis. , 2008, Arthritis and rheumatism.
[337] Steven P. Cohen,et al. The Effect of Opioid Dose and Treatment Duration on the Perception of a Painful Standardized Clinical Stimulus , 2007, Regional Anesthesia & Pain Medicine.
[338] H. Rittner,et al. Immune System, Pain and Analgesia , 2020, The Senses: A Comprehensive Reference.
[339] R. Houghten,et al. Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. , 2008, European journal of pharmacology.
[340] A. Dahan,et al. Morphine-6-glucuronide: potency and safety compared with morphine , 2008, Expert opinion on pharmacotherapy.
[341] C. Sen,et al. Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. , 2008, Physiological genomics.
[342] M. Angst,et al. Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision , 2008, Molecular pain.
[343] K. Lorenz,et al. Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling. , 2008, Nature chemical biology.
[344] C. Stein,et al. Opioids and sensory nerves. , 2009, Handbook of experimental pharmacology.
[345] K. Ohshima,et al. Immunohistochemical detection of chemokines in human skin wounds and its application to wound age determination , 2002, International Journal of Legal Medicine.
[346] C. Stein,et al. Peripheral mechanisms of opioid analgesia. , 2009, Current opinion in pharmacology.
[347] E. Bruera,et al. Textbook of Palliative Medicine , 2009 .
[348] A. Kopf,et al. Topical administration of analgesics , 2009 .